In This Section

13th Biennial Ovarian Cancer Research Symposium

Presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research

September 26-28, 2020
Hyatt Regency Seattle
Seattle, Washington

Abstract Submission DeadlineMonday, July 13, 2020, 11:59 p.m. ET
Award Application DeadlineMonday, July 13, 2020, 11:59 p.m. ET
Advance Registration DeadlineMonday, August 10, 2020, 11:59 p.m. ET

Conference Cochairs

Douglas A. Levine, New York University, New York, New York
Ursula A. Matulonis, Dana-Farber Cancer Institute, Boston, Massachusetts
Barbara Norquist, University of Washington, Seattle, Washington
Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, New York

Visit Meeting Website

The goal of the Symposium is to bring together clinicians and researchers from across many disciplines and institutions worldwide in order to encourage collaborations toward advancing the field of ovarian cancer research. The conference seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior investigators; discuss the most recent innovations in the field of ovarian cancer research; and address pressing concerns of the leaders in the clinical and research community.

Session Topics Will Include:

  • DNA Repair and Mechanisms
  • Immuno-oncology
  • Model Systems
  • Novel Therapeutics
  • Prevention and Early Detection
  • Rare Tumors

Professional Educational Grants

GlaxoSmithKline

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available